Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study
Langohr, H.D.; Reinecke, M.; Gerber, W.D.; Mangold, R.
Fortschritte der Medizin 106(2): 65
1988
ISSN/ISBN: 0015-8178 PMID: 3278960 Document Number: 323827
Document emailed within 1 workday
Related Documents
Grotemeyer, K.H.; Schlake, H.P.; Husstedt, I.W. 1988: Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study Der Nervenarzt 59(9): 549-552Pothmann, R. 1987: Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(9): 646-649
Frenken, C.W.; Nuijten, S.T. 1984: Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo Fortschritte der Medizin 102(12): 349-351
Paterna, S.; Martino, S.G.; Campisi, D.; Cascio Ingurgio, N.; Marsala, B.A. 1990: Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study La Clinica Terapeutica 134(2): 119-125
Wörz, R.; Reinhardt-Benmalek, B.; Föh, M.; Grotemeyer, K.H.; Scharafinski, H.W. 1992: Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol Fortschritte der Medizin 110(14): 268-272
Rompel, H.; Bauermeister, P.W. 1970: Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study South African Medical Journal 44(4): 75-80
Lynggaard, F.; Ostergaard, F. 1975: Clonidine in prevention of migraine. Report of a double-blind study of 38 patients referred for neurological assessment Ugeskrift for Laeger 137(3): 149-151
Nelson, M.; Dewitz, G.; Dom, J.; Hörig, C. 1978: Study on the effect of Sibelium (flunarizine) in blood circulation disorders. a multicentric double-blind study Die Medizinische Welt 29(29-30): 1175-1181
Agnoli, A.; Manna, V.; Martucci, N.; Fioravanti, M.; Ferromilone, F.; Cananzi, A.; D'Andrea, G.; De Rosa, A.; Vizioli, R.; Sinforiani, E. 1988: Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders International Journal of Clinical Pharmacology Research 8(3): 189-197
Vo, A.H.; Satori, R.; Jabbari, B.; Green, J.; Killgore, W.D.S.; Labutta, R.; Campbell, W.W. 2007: Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial Aviation Space and Environmental Medicine 78(5 Suppl): B113-B118
Gough, K.R.; Bardhan, K.D.; Crowe, J.P.; Korman, M.G.; Lee, F.I.; Reed, P.I.; Smith, R.N. 1985: Ranitidine and cimetidine in the prevention of recurrence of duodenal ulcer. A randomized, double-blind, multicenter comparative study Fortschritte der Medizin 103(37): 878-882
Baust, W.; Stürtzbecher, K.H. 1978: Management of migraine using acupuncture in a double-blind study Die Medizinische Welt 29(16): 669-673
Heuser, B.; Middendorf, E. 1985: Migraine prevention with dihydroergotamine Fortschritte der Medizin 103(41): 966-970
Di Trapani, G.; Mei, D.; Marra, C.; Mazza, S.; Capuano, A. 2000: Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study La Clinica Terapeutica 151(3): 145-148
Gerber, W.D.; Schellenberg, R.; Thom, M.; Haufe, C.; Bölsche, F.; Wedekind, W.; Niederberger, U.; Soyka, D. 1995: Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study Functional Neurology 10(1): 27-35
Russell, M.B.; Holm-Thomsen, O.E.; Nielsen, M.R.; Cleal, A.; Pilgrim, A.J.; Olesen, J. 1995: Sumatriptan treatment of migraine in general practice. a randomized, double-blind, placebo-controlled cross-over study Ugeskrift for Laeger 157(16): 2320-2323
Sulman, F.G.; Pfeifer, Y.; Superstine, E. 1981: Preventive treatment of serotonin-migraine with 1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino-(1,2--d)-(1,4)-oxazepine hydrogen maleate (Org GC 94). A double-blind study Arzneimittel-Forschung 31(1): 109-112
Salonen, R.; Ashford, E.A.; Gibbs, M.; Hassani, H. 1999: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group International Journal of Clinical Practice. Supplement 105: 16-24
Moshal, M.G.; Spitaels, J.M.; Khan, F. 1981: Tri-potassium di citrato bismuthate chewing tablets and cimetidine tablets in the treatment of duodenal ulcers. a double-blind double-dummy comparative study South African Medical Journal 60(11): 420-423
Savani, N.; Brautaset, N.J.; Reunanen, M.; Szirmai, I.; Ashford, E.A.; Hassani, H.; Saiers, J. 1999: A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group International Journal of Clinical Practice. Suppl 105: 7-15